Select for export Psychedelics not linked to mental health problems or suicidal behavior: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568039 PubMed 25744618 Copy citation Copy BibTeX Journal of Psychopharmacology 2015-03-04 Johansen PØ, Krebs TS. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114565653 PubMed 25586402 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2015-02-28 Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW PubMed Published psilocybin Observational Study Observational Study More
Select for export Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568040 PubMed 25670401 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2015-02-28 Majić T, Schmidt TT, Gallinat J PubMed Published psilocybin AnxietyAddictionOCD Clinical Trial More
Select for export Drug models of schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125314557797 PubMed 25653831 Copy citation Copy BibTeX Therapeutic advances in psychopharmacology 2015-01-31 Steeds H, Carhart-Harris RL, Stone JM PubMed Published psilocybin AddictionReview ArticleDrug Interactions Review Article More
Select for export Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114565144 PubMed 25586396 Copy citation Copy BibTeX Journal of Psychopharmacology 2015-01-12 Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Qualitative Study More
Select for export P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(14)70316-5 Copy citation Copy BibTeX European Neuropsychopharmacology 2014-09-24 Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyEmotional Processing Other More
Select for export Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114548296 PubMed 25213996 Copy citation Copy BibTeX Journal of Psychopharmacology 2014-09-10 Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Europe PMC Published psilocybin AddictionReceptor PharmacologyBiomarkers Other More
Select for export Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125314527985 PubMed 25083275 Copy citation Copy BibTeX Therapeutic advances in psychopharmacology 2014-07-31 Baumeister D, Barnes G, Giaroli G, Tracy D PubMed Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.bbr.2014.07.016 PubMed 25036425 Copy citation Copy BibTeX Unknown journal 2014-07-14 Halberstadt AL. Europe PMC Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513851 PubMed 24399338 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2013-12-31 Hendricks PS, Clark CB, Johnson MW, Fontaine KR, Cropsey KL PubMed Published psilocybin Addiction Other More
Select for export Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513852 PubMed 24284475 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-11-26 Winstock AR, Kaar S, Borschmann R. Europe PMC Published psilocybin Observational StudyAbuse Liability Observational Study More
Select for export PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/jnnp-2013-306103.17 Copy citation Copy BibTeX Journal of Neurology Neurosurgery & Psychiatry 2013-08-05 Robin Carhart-Harris OpenAlex Published psilocybin AnxietyEnd-of-Life DistressBrain Imaging Clinical Trial More
Select for export Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113494107 PubMed 23784738 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-06-18 Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. Europe PMC Published psilocybin Depression Other More
Select for export The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2811-0 PubMed 22836372 Copy citation Copy BibTeX Psychopharmacology 2012-07-26 Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. Europe PMC Published psilocybin Receptor PharmacologyEmotional Processing Other More
Select for export Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/hup.2234 PubMed 22696164 Copy citation Copy BibTeX Human Psychopharmacology Clinical and Experimental 2012-06-13 Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM Europe PMC Published psilocybin AddictionObservational StudyAdolescents Observational Study More
Select for export Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.26.1_supplement.1043.3 Copy citation Copy BibTeX The FASEB Journal 2012-03-31 Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881111420188 PubMed 21956378 Copy citation Copy BibTeX Journal of Psychopharmacology 2011-09-27 MacLean KA, Johnson MW, Griffiths RR. Europe PMC Published psilocybin Personality ChangeCreativitySpirituality Randomized Controlled Trial More
Select for export Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.228 PubMed 21956447 Copy citation Copy BibTeX Neuropsychopharmacology 2011-09-27 Quednow BB, Kometer M, Geyer MA, Vollenweider FX. Europe PMC Published psilocybinpsilocin Receptor PharmacologyConsciousnessObservational Study Clinical Trial More
Select for export P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(11)70495-3 Copy citation Copy BibTeX European Neuropsychopharmacology 2011-08-06 Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt OpenAlex Published psilocybin Mechanism of ActionCancer Patients Other More
Select for export Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-011-2358-5 PubMed 21674151 Copy citation Copy BibTeX Psychopharmacology 2011-06-14 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Clinical Trial More
